|Bid||4.97 x 3100|
|Ask||5.05 x 3000|
|Day's Range||4.7300 - 5.0604|
|52 Week Range||2.6450 - 66.5600|
|Beta (3Y Monthly)||-3.29|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 8, 2018 - Aug 13, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.00|
Demonstrating its commitment to advancing its GoodWheat™ portfolio of novel, non-GM wheat ingredients with unique health benefits to commercialization, Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced additional progress in the development of its supply chain, led by Grant Aldridge, the company’s new Head of Commercial Development. Since mid-2018, Arcadia has significantly expanded its grower base for unique GoodWheat varieties to provide adequate supply for its consumer and animal feed customers. To preserve the unique characteristics of GoodWheat, the company has developed a robust identity preservation system that ensures the wheat’s unique quality is maintained throughout the supply chain, from seed to food company.
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today announced that it will be featured as a presenting company at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, at the W Hotel in Fort Lauderdale, Florida.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that its lawsuit in the United States District Court for the Southern District of New York against Arista Cereal Technologies, Pty. Ltd. has ended based on a jurisdictional decision by the court. The lawsuit sought to correct inventorship on key patents for Arista’s high-amylose wheat. “The vast majority of our GoodWheat™ portfolio as well as the overall target market for our wheat, soy and other nutrition and ingredient products is unaffected by our dispute with Arista.
NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Arcadia Biosciences and Achaogen were two winners in the biotech arena on Monday. Achaogen soared over 20% on positive clearance news for the Thermo Scientific QMS Plazomicin Immunoassay. There was no remarkable news from Arcadia Biosciences to explain the jump.
In 2016 Raj Ketkar was appointed CEO of Arcadia Biosciences Inc (NASDAQ:RKDA). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar Read More...
A project of Ardent Mills and a research partner is yielding something farmers, food producers and consumers all want. The Denver-based milling giant and Arcadia Biosciences Inc. (Nasdaq: RKDA), a Davis, California-based food ingredients company, plan to jointly commercialize new wheat strains the companies say will make whole-wheat products live longer on store shelves and taste better, too. The wheat is the result of Arcadia Biosciences’ research into non-genetically modified wheat traits that Ardent Mills is licensing to encourage farmers and food producers to use.
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 59.29% and 42.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Davis, California-based company said it had net income of 93 cents. Losses, adjusted for non-recurring gains, came to 46 cents per share. The agricultural biotechnology trait ...
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today released its financial and business results for the third quarter and first nine months of 2018.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, and Ardent Mills, LLC, North America’s leading flour-milling and ingredient company, today announced a collaboration to develop and commercialize innovative wheat varieties.
Verdeca, a joint venture between Arcadia Biosciences, Inc. (RKDA) and Bioceres S.A., announced today that it has received approval in Argentina for its HB4 drought tolerant trait stacked with herbicide tolerant traits in soybeans. Argentina’s Secretariat of Food and Bioeconomy evaluated the food, feed, environment and commercial impact of the stacked traits and approved them for deregulation contingent upon trade approval by China. The HB4-herbicide tolerance trait stack is Verdeca’s newest release from its pipeline of traits developed to benefit soybean producers through quality improvement or stress mitigation.
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today announced that it will release its third-quarter 2018 financial and business results after market close on November 7, 2018.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that the United States Patent and Trademark Office has granted the company a patent for extended shelf life wheat, the newest trait in Arcadia’s non-genetically modified (non-GM) GoodWheat™ portfolio. This new trait was designed to promote whole wheat consumption by improving the shelf life and taste of whole grain wheat products. “This patent demonstrates our commitment to developing exciting innovations for consumers and food companies to drive the adoption of whole wheat,” said Raj Ketkar, president and CEO of Arcadia.
If you want to know who really controls Arcadia Biosciences Inc (NASDAQ:RKDA), then you’ll have to look at the makeup of its share registry. Insiders often own a large chunkRead More...
Boohoo (BOOH.L), the fast-growing British online fashion retailer, has appointed a Primark executive as its new CEO to drive the brand's global expansion, on a pay package that could earn him almost 58 million pounds in five years. In a move that will see the company's co-founders step back from the day-today running of the business, Boohoo said John Lyttle, currently chief operating officer at Associated British Foods' (ABF.L) Primark business, will start in March next year. Lyttle, who has also worked for Matalan and Philip Green's Arcadia group, oversaw a rise in turnover at Primark to 7.1 billion pounds in 2017 from 2.7 billion pounds in 2010.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that it has filed a notice of appeal to the United States Court of Appeal for the Federal Circuit (Federal Circuit) and a lawsuit in the United States District Court for the Southern District of New York (SDNY) against Arista Cereal Ingredients, Pty. Ltd. and two of its affiliates. The actions are related to Arcadia’s high-fiber Resistant Starch (RS) wheat.
Arista Cereal Technologies Pty Ltd (ARISTA) is pleased to announce that it has successfully defended a patent in its portfolio covering a form of wheat having greatly elevated fiber levels. Arcadia Biosciences Inc. (RKDA) provoked a dispute in the U.S. Patent and Trademark Office (USPTO) in September 2017 against ARISTA's patent. On August 14, 2018, the Patent Trials and Appeals Board of the USPTO issued a decision finding that the patent application filed by Arcadia Biosciences to provoke the dispute did not describe the invention claimed in ARISTA's patent and issued a judgement against Arcadia Biosciences on priority of invention.
Arcadia Biosciences, Inc. (RKDA), an agricultural food ingredient company, today announced that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co. LLC. The conference is being held September 4-6 at the St. Regis Hotel in New York City. Raj Ketkar, Arcadia’s president and CEO, will present a business overview at 10:50 a.m. EDT on Wednesday, September 5, 2018. Ketkar and Matthew Plavan, chief financial officer, will be available September 5-6 for meetings with investors.
On a per-share basis, the Davis, California-based company said it had a loss of $2.02. The agricultural biotechnology trait company posted revenue of $436,000 in the period. Arcadia Biosciences shares ...
Arcadia Biosciences, Inc. , an agricultural food ingredient company, today released its financial and business results for the second quarter and first half of 2018.